Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SFRP1 ELISA Kit (AC3242)
Cat.#: ASET-1831
Specifications
Description Human SFRP1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SFRP1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.46 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15-240 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2260 Mouse LAMP1 ELISA Kit (AC3671) Quantitative inquiry ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry ASET-1908 Mouse NCAM1 ELISA Kit (AC3319) Quantitative inquiry ASET-1171 Human SYT6 ELISA Kit (AC2582) Quantitative inquiry ASET-2320 Mouse Semaphorin 3A ELISA Kit (AC3731) Quantitative inquiry ASET-2009 Human Ndufs1 ELISA Kit (AC3420) Quantitative inquiry ASET-1792 Human PGRPS ELISA Kit (AC3203) Quantitative inquiry ASET-1476 Mouse Amyloid Precursor Protein ELISA Kit (AC2887) Quantitative inquiry ASET-2250 Rat PCDHB5 ELISA Kit (AC3661) Quantitative inquiry ASET-2275 Human Calbindin ELISA Kit (AC3686) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket